Last checked at 
LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
PANMURE CUTS TRAVIS PERKINS TO 'SELL' ('BUY') - TARGET 1950 (2300) PENCE
----------
HSBC RAISES INMARSAT PRICE TARGET TO 1020 (920) PENCE - 'HOLD'
----------
HSBC RAISES BARCLAYS PRICE TARGET TO 315 (290) PENCE - 'BUY'
----------
MACQUARIE RAISES BARCLAYS PRICE TARGET TO 310 (285) PENCE - 'OUTPERFORM'
----------
MACQUARIE RAISES RIO TINTO TO 'OUTPERFORM' ('NEUTRAL') - PRICE TARGET 3300 PENCE
----------
DEUTSCHE BANK RAISES RIO TINTO PRICE TARGET TO 3800 (3600) PENCE - 'BUY'
----------
HSBC CUTS RIO TINTO PRICE TARGET TO 27.90 (28) PENCE - 'HOLD'
----------
UBS RAISES OLD MUTUAL PRICE TARGET TO 255 (247) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS PRUDENTIAL PRICE TARGET TO 1850 (1900) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES MONDI PRICE TARGET TO 1750 (1640) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES STANDARD CHARTERED TO 'HOLD' ('SELL')- TARGET 918 (864) PENCE
----------
EXANE BNP CUTS STANDARD CHARTERED PRICE TARGET TO 900 (1000) P.- 'UNDERPERFORM'
----------
JPMORGAN CUTS MERLIN PRICE TARGET TO 430 (450) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS STANDARD CHARTERED PRICE TARGET TO 900 (1000) P.- 'UNDERPERFORM'
----------
JPMORGAN RAISES INMARSAT PRICE TARGET TO 1050 (910) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS NEXT TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 7700 PENCE
----------
JPMORGAN RAISES BAT PRICE TARGET TO 4350 (4100) PENCE - 'OVERWEIGHT'
----------
JEFFERIES CUTS MERLIN ENTERTAINMENTS PRICE TARGET TO 470 (500) PENCE - 'BUY'
----------
JEFFERIES RAISES GLAXOSMITHKLINE PRICE TARGET TO 1500 (1350) PENCE - 'HOLD'
----------
JEFFERIES RAISES ASTRAZENECA PRICE TARGET TO 5600 (5400) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES MONDI PRICE TARGET TO 1815 (1670) P. - 'OUTPERFORM'
----------
FTSE 250
----------
CREDIT SUISSE RAISES AGGREKO TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 1065 PENCE
----------
BERENBERG CUTS AGGREKO TO 'SELL' ('HOLD') - TARGET 980 (1200) PENCE
----------
HSBC RAISES DAIRY CREST GROUP PRICE TARGET TO 710 (590) PENCE - 'BUY'
----------
SHORE CAPITAL CUTS WILLIAM HILL TO 'HOLD' ('BUY')
----------
SOCGEN RAISES COBHAM TO 'HOLD' ('SELL') - TARGET 310 PENCE
----------
LIBERUM RAISES COBHAM TO 'BUY' ('HOLD') - TARGET 330 (315) PENCE
----------
JPMORGAN RAISES WIZZ AIR PRICE TARGET TO 1750 (1700) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES RENTOKIL INITIAL PRICE TARGET TO 120 (110) P - 'UNDERWEIGHT'
----------
JPMORGAN RAISES COBHAM PRICE TARGET TO 305 (295) PENCE - 'OVERWEIGHT'
----------
JEFFERIES CUTS SPIRAX-SARCO PRICE TARGET TO 3290 (3375) PENCE - 'HOLD'
----------
SOCGEN RAISES BRITVIC TO 'BUY' ('HOLD') - TARGET 800 (785) PENCE
----------
MAIN MARKET AND AIM
----------
CREDIT SUISSE CUTS GENEL ENERGY PRICE TARGET TO 685 (900) PENCE - 'OUTPERFORM'
----------
UBS CUTS GENEL ENERGY PRICE TARGET TO 585 (650) PENCE - 'BUY'
----------
DEUTSCHE BANK INITIATES SOPHOS WITH 'BUY' - TARGET 300 PENCE
----------
MACQUARIE INITIATES SECURE TRUST BANK WITH 'OUTPERFORM'
----------
UBS CUTS SPIRENT TO 'NEUTRAL' ('BUY') - TARGET 84 (95) PENCE
----------
Liberum Ups Kerry Group Price Target To EUR69.00 From EUR68.50, Retains Hold
----------
CITIGROUP CUTS XCHANGING PRICE TARGET TO 140 (160) PENCE - 'BUY'
----------
Cantor Fitzgerald Lifts Victoria Price Target To 1,400p From 1,200p, Keeps Buy
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
2 May 2024 19:57
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.
Read more